Resources
Depression
A Randomized Placebo-Controlled Pet Study of Ketamine’s Effect on Serotonin1B Receptor Binding in Patients With SSRI-Resistant Depression
Translational Psychiatry | June 2020
Comprehensive Assessment of Side Effects Associated With a Single Dose of Ketamine in Treatment-Resistant Depression
Journal of Affective Disorders | November 2019
Intravenous Ketamine for Adolescents With Treatment-Resistant Depression: An Open-Label Study
Journal of Child and Adolescent Psychopharmacology | July 2018
Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
American Journal of Psychiatry | December 2017
World-First Ketamine Trial Shows Promise for Geriatric Depression
American Journal of Geriatric Psychiatry | July 2017
FDA Data Support Ketamine as Depression Therapy
MedPage Today | May 2017
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
Am J Psychiatry | October 2013
Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
Biological Psychiatry | August 2013
Serial Infusions of Low-Dose Ketamine for Major Depression
Journal of Psychopharmacology | May 2013
Ketamine as a Novel Antidepressant: From Synapse to Behavior
Clinical Pharmacology & Therapeutics | December 2011
Anxiety
Effects of Ketamine in Patients With Treatment-Refractory Generalized Anxiety and Social Anxiety Disorders
Journal of Psychopharmacology | Sept 2019
Safety and Efficacy of Maintenance Ketamine Treatment in Patients With Treatment-Refractory Generalized Anxiety and Social Anxiety Disorders
Journal of Psychopharmacology | March 2018
Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial
Neuropsychopharmacology | Jan 2018
Ketamine’s Dose-Related Effects on Anxiety Symptoms in Patients With Treatment-Refractory Anxiety Disorders
Journal of Psychopharmacology | April 2017
PTSD | Ketamine & SGB
Effect of SGB Treatment on PTSD
JAMA | November 2019
New Promise for Treating PTSD
Psychology Today | August 2019
Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder: A Randomized Clinical Trial
JAMA Psychiatry | June 2014
Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression
J Clin Psychiatry | May/June 2018
Ketamine As Treatment For Post-Traumatic Stress Disorder: A Review
NIH | April 2019
Chronic Pain | Migraines, CRPS, Neuropathy
The Use of Ketamine Infusions for Refractory Headaches: A Retrospective Analysis
Am Society of Anesthesiologists | October 2017
Multi-Day Low Dose Ketamine Infusion for the Treatment of Complex Regional Pain Syndrome
Pain Physician | April 2005
Subanesthetic Ketamine Infusion Therapy: A Retrospective Analysis of a Novel Therapeutic Approach to Complex Regional Pain Syndrome
Pain Medicine | September 2004
Other
Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-Of-Concept
Neuropsychopharmacology | November 2013
NAVIGATE
QUICK LINKS
